SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


National Association for Continuing Education
Course Reviewer
Kalyan Ram Bhamidimarri, MD, MPH
Associate Professor
Chief, Division of Hepatology
University of Miami
Miami, FL

Medical Writer
Cedric Nazareth, MBBS

Title
: Identifying Primary Biliary Cholangitis: An Old Condition with New Therapy
Activity/Course #:
: NCME378
Cost:
: Free
Release/Start Date:
: Jun 18 2019
Expiration Date:
: Jun 18 2020
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Physicians, Nurse Practitioners, Physician Assistants
Format:
: Monograph
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s)
Hardware/Software Requirements:
Summary
Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic inflammatory disease of the liver, which if untreated results in end-stage biliary cirrhosis and portal hypertension, with associated symptoms and negative effects on quality of life (QoL). Evaluation and timely diagnosis is important because treatment is available for PBC and some of its symptoms.

This activity will review the epidemiology and pathophysiology of PBC, how to recognize and evaluate a patient for PBC, and the treatment of PBC, including the treatment of extrahepatic manifestations.

Learning Objective(s):

After completing this program participants should be able to:

  1. Review the epidemiology of primary biliary cholangitis (PBC)
  2. Describe the pathophysiology of PBC
  3. Recognize how to evaluate a patient for PBC
  4. Discuss the treatment of PBC, including the treatment of extrahepatic manifestations

How to obtain the CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education which includes 0.75 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Activity Planning Committee,
Kalyan Ram Bhamidimarri, MD, MPH serves on the scientific advisory board for Gilead, AbbVie, Merck, and Intercept Pharmaceuticals, Inc. Dr. Bhamidimarri is a disease state education speaker for Alexion. He has also received research grant support from Gilead, Conatus, Allergan/Tobira, and Genfit.

Gregg Sherman, MD, has no relationships to disclose.

Cedrick Nazareth, Medical Writer, has no relationships to disclose.

Deborah Paschal, CRNP, has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Alan Goodstat, LCSW, has no relationships to disclose.

Daniela Hiedra, BA, has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationships to disclose.

Alan Goodstat, LCSW, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from Intercept Pharmaceuticals.